Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Total 13F shares
-
3,193,668
-
Share change
-
+1,505,083
-
Total reported value
-
$7,438,573
-
Price per share
-
$2.33
-
Number of holders
-
25
-
Value change
-
+$3,519,290
-
Number of buys
-
15
-
Number of sells
-
3
Institutional Holders of PDS Biotechnology Corp - Common (PDSB) as of Q3 2020
As of 30 Sep 2020,
PDS Biotechnology Corp - Common (PDSB) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,193,668 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, FEDERATED HERMES, INC., INSPIRION WEALTH ADVISORS, LLC, FIRST MANHATTAN CO, Sofinnova Investments, Inc., New Leaf Venture Partners, L.L.C., UBS Group AG, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.